India COVID-19 Clinical Trials Market Analysis

India COVID-19 Clinical Trials Market Analysis

$ 3999

This report presents a strategic analysis of the India COVID-19 Clinical Trials Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the India COVID-19 Clinical Trials Market, offering unmatched value, accuracy and expert insights.

ID: IN10INCT003 CATEGORY: Clinical Trials GEOGRAPHY: India

Buy Now

India COVID-19 Clinical Trials Market Executive Summary

With a population of more than 1.2 billion, India is the world’s largest democracy. Over the past decade, the country’s integration into the global economy has been accompanied by economic growth. India has now emerged as a global player. Since the 2000s, India has made remarkable progress in reducing absolute poverty. Between 2011 and 2015, more than 90 million people were lifted out of extreme poverty.

Healthcare has become one of India’s largest sectors, both in terms of revenue and employment. Rising income, higher health awareness, lifestyle disorders, and more access to insurance are predicted to boost the Indian healthcare market to US$ 372 billion by 2022. As of 2021, the Indian healthcare sector is one of India’s largest employers as it employs a total of 4.7 million people. The sector generated 2.7 million additional jobs in India between 2017-22, over 500,000 new jobs per year.

Clinical trials are a method of doing clinical research that is guided by a detailed protocol that has been carefully created to address a specific patient care question. Clinical trials can be broken down into five phases, each of which serves a particular function. Every trial follows a protocol that specifies the kinds of people who are allowed to take part in the study. In addition to stating the duration of the study, the studies also detail the precise plan of operations, tests, drugs, and doses inside the experiment. The rising expenses of drug development in recent years have forced pharma and biotech companies to explore modernizations and more efficient ways of operating.

Due to the virus's resurgence in major areas in 2020, the Covid-19 market is old. As a result, the growth of the clinical trial industry, which included prescription drugs and vaccines among others, picked up steam in the final quarter of 2020. Vaccines and treatments to treat or prevent disease are the two main products driving the clinical trial industry. Due to the increasing number of cases on a global scale, the globalization of clinical trials across countries, as well as medical technology improvements, the industry is expected to expand throughout the forecast period.

Major pharmaceutical companies like Pfizer, Moderna, Novartis, and others produced their mRNA vaccines at record speed with greater efficacy and safety. Similar advancements in the COVID-19 clinical trials sector would propel the markets and improve the outlook for the sector as a whole.

Market Size and Key Findings

The India COVID-19 Clinical Trials Market size is around US $ xx Bn in 2021 and is projected to reach US $ xx Bn in 2030, exhibiting a CAGR of xx% during the forecast period.

India COVID-19 Clinical Trials Market Size (In USD Bn) (2021-2030F)

Market Dynamics

Market Growth Drivers Analysis

The demand for the Clinical trials market is increasing due to the prevalence of chronic diseases driving the demand, the growing demand for outsourcing clinical trials to CROs, the rise in government and non-government funding for clinical trials, and growing opportunities for conducting clinical trials in countries of Asia Pacific.

 Market Restraints

Inadequate research facilities and infrastructures to support their management and development, particularly when trial sites are dispersed across multiple countries, are one of the factors limiting the market growth. Specialized academic clinical trial units (CTUs) and clinical research centres (CRCs), which are designed to provide services like clinical trials for any particular disease, are examples of research infrastructures. However, in some nations, particularly in middle-income countries where there is insufficient government funding for clinical trials, such facilities are not only completely absent but also hard to come by. As a result, the development of the market is threatened by the lack of adequate infrastructure, which makes it necessary for clinical trials to be conducted in low- and middle-income countries with well-developed infrastructure.

Competitive Landscape

Key Players

Moderna, Inc., GlaxoSmithKline plc, Pfizer Inc., Johnson & Johnson, Gilead Sciences Inc., INOVIO Pharmaceuticals, AbbVie Inc., BioNTech SE, Novavax, Takeda are a few companies active in the market. 

1. Report Description of the India COVID-19 Clinical Trials Market
1.1 Research Scope and Assumption
1.2 Objective of the study
1.3 Research Methodology
1.4 Reason to buy the report

2. India COVID-19 Clinical Trials Market Executive Summary
2.1 India COVID-19 Clinical Trials Market – Industry Snapshot & key buying criteria, 2021-2030
2.2 Market Size, Growth Prospects, and Key findings

3. Market Dynamics of India COVID-19 Clinical Trials Market
3.1 Market Growth Drivers Analysis
3.2 Market Restrains Analysis

4. India COVID-19 Clinical Trials Market Segmentation

4.1 By Phase Outlook
4.1.1 Phase I
4.1.2 Phase II
4.1.3 Phase III
4.1.4 Phase IV
4.1.5 Others

4.2 By Product
4.2.1 Therapeutics
4.2.2 Vaccines

5. India COVID-19 Clinical Trials Market Share
5.1 Market Analysis, Insights, and Forecast – By Revenue

6. Competitive Landscape
6.1 Major Top Market Players

7. Key Company Profiles

7.1 Company 1
7.1.1 Overview
7.1.2 Financial Performance
7.1.3 Product & Services
7.1.4 Strategic initiatives

7.2 Company 2
7.2.1 Overview
7.2.2 Financial Performance
7.2.3 Product & Services
7.2.4 Strategic initiatives

7.3 Company 3
7.3.1 Overview
7.3.2 Financial Performance
7.3.3 Product & Services
7.3.4 Strategic initiatives

7. Company 4
7.4.1 Overview
7.4.2 Financial Performance
7.4.3 Product & Services
7.4.4 Strategic initiatives

7.5 Company 5
7.5.1 Overview
7.5.2 Financial Performance
7.5.3 Product & Services
7.5.4 Strategic initiatives

8. Healthcare Policies and Regulatory Landscape
8.1 Healthcare Policies in India
8.2 Regulatory Framework in India
8.3 Pricing & Reimbursement Scenario in India COVID-19 Clinical Trials Market

9. Factors Driving Future Growth
9.1 New Trends and Development India COVID-19 Clinical Trials Market
9.2 Future Opportunities

10. Strategic Recommendations

COVID-19 Clinical Trials Market Segmentation

By Phase (Revenue, USD Billion):

Based on Phase the COVID-19 Clinical Trials are examined

  • Phase I
  • Phase II
  • Phase III
  • Phase IV
  • Others

By Outlook (Revenue, USD Billion):

Based on type the market examined by Therapeutics and Vaccines

  • ?Therapeutics
  • ? Vaccines

Insights10 will provide you with the reports within 10 key parameters which are:

  1. Market Overview
  2. Market Growth Drivers & Restraints
  3. Epidemiology of Disease Type
  4. Market Segmentation
  5. Market Share
  6. Competitive Landscape
  7. Key Company Profiles
  8. Healthcare Policies & Regulatory Framework
  9. Reimbursement Scenario
  10. Factors Driving Future Growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision-making for business stakeholders. Our focused approach to developing reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.


Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers, and researchers across countries through which we engage with local experts to gather key data points and assumptions about each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain a high level of accuracy and consistency. The market data is analyzed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, and market share as well as a segment-level analysis of the specific market. Our report includes precise, to-the-point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:



Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameters and micro indicators. The macro parameters include changes in government policies, demand and supply of the market, government intervention programs, and major market share. The micro indicators are GDP growth, market size, market volume, etc. We also understand nuances specific to each country like the US, Canada, India, Germany, etc., and have worked across 60+ countries and hence not only understand global trends but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. starting with the large overall market and segmenting different areas and the bottom-up approach i.e. starting with population and epidemiology and rolling up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach is mainly used for new product forecasting and the bottom-up approach is used for demand estimation of any product for different countries summed up to form the total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as Asia-Pacific, Africa, Europe, Middle East, North America, and  Latin America for the period of 2022 to 2030. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape, and policy and regulatory scenario, and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases, and company-level averages, etc.

We make sure to finalize the numbers in alignment with the market research. Firstly, our internal experts ensure thorough validation and checking to ensure accurate and precise analysis and then validation is also done using a multiple-data analysis model. Two-level validation is done and entails the finalization of the report scope and the way of representation pattern.



Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analyzed and synthesized. The second series of interviews are done if necessary to check and validate. The future opportunities are analyzed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results is then, interpreted by considering the following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing the regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue/volume
  • ​Analyzing current needs and determining penetration to estimate the market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and their impact on the different segments within the market.

Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current, and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumption.

The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy of this report, please complete the form below.

We value your inquiry and offer free customization with every report to fulfil your exact research needs.

This report addresses

  • Intelligent insights to take informed business decisions
  • Qualitative, acute and result oriented market analysis
  • Market size and forecasts from 2022 to 2030
  • Opportunities for expansion and in-depth market analysis
  • Segmentation and regional revenue forecasts
  • Analysis of the market share and competitive landscape
  • Strategic Recommendations to chart future course of action
  • Comprehensive Market Research Report in PDF and PPT formats

Need more?

  • Ask our analyst how this study was put together to learn more
  • Discuss additional requirements as part of the free customisation
  • Add more countries or regions to the scope 
  • Get answers to specific business questions 
  • Develop the business case to launch the product
  • Find out how this report may influence your business revenue
Last updated on: 04 January 2023

Related reports (by category)

Related reports (by geography)

subscribe to our newsletter